地拉罗司医保价格

(Enrig) was approved by the FDA in November 2005 for use in patients 2 years and older with chronic iron overload caused by blood transfusions. In December 2012, Deferasirox (Enrige) was approved by the European Commission for the treatment of chronic iron overload in patients aged 10 years and above with non-transfusion-dependent thalassemia (NTDT) syndrome who require chelation therapy due to contraindications or insufficiency of deferoxamine mesylate therapy. On January 23, 2013, the FDA approved a new indication for deferasirox (Enrige) for the treatment of chronic iron overload in patients aged 10 years and older with non-transfusion-dependent thalassemia (NTDT). In 2010, Deferasirox (Enrige) was approved for marketing in China and is used to treat chronic iron overload caused by frequent blood transfusions (monthly administration of concentrated red blood cells ≥7mL/kg) in patients with β-thalassemia older than 6 years old; iron overload caused by children under 6 years old and other transfusion-dependent diseases. What is the medical insurance price of Deferasirox (Enrige)? Let's take a look.

According to Medical Companion Travel, Deferasirox (Enrige) has not yet been officially included in medical insurance and cannot be reimbursed by medical insurance. It is a drug paid for by the patient at his own expense. The price of Deferasirox (Enrego) is relatively high after it is launched in China, with a box costing about $2,000. For an ordinary person weighing 60kg, the cost of taking Deferasirox (Enrige) for a month exceeds about $24,000. Fortunately, there are also foreign versions for everyone to choose from. Novartis of Switzerland imported deferasirox (Enrego) into India. The specification is 400mg*30 tablets/box, and the price is about $700.

The specification of Deferasirox (Enrego) produced by Indian pharmaceutical factory is 500*30 tablets/box, and the price is about 500$. Due to the fluctuation of exchange rate, the price will be different. Please consult the medical companion for the specific price.

Regarding use by special groups (Enrige): 1. For pregnant women, children under 6 years old, the elderly, and pregnant women, deferasirox should be used with caution. 2. Deferasirox should not be used by children under 2 years old; 3. It is prohibited for those who are allergic to deferasirox and related ingredients.

Related hot article recommendations: